Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma.
Jerby-Arnon L., Neftel C., Shore M.E., Weisman H.R., Mathewson N.D., McBride M.J., Haas B., Izar B., Volorio A., Boulay G. et al., 2021/02. Nature medicine, 27 (2) pp. 289-300. Peer-reviewed.
ici le détail